Title: Prevalence of Microalbuminuria in Patients with Thyroid Dysfunction
Authors: Sowmya Sridharan, Santhi Thoppappatty Sengottaiyan, Gurusamy Gurunamasivayam, Palani Kannan
DOI: https://dx.doi.org/10.18535/jmscr/v5i6.193
Abstract
Background: In India, 42 million people suffer from various kinds of thyroid disorders. Thyroid dysfunction and microalbuminuria are associated with endothelial dysfunction. Thus establishing a relationship between the two can play a significant role in prevention of endothelial dysfunction and hence modify diseases like obesity hypertension, diabetes, chronic kidney disease, cardiovascular disease which also have endothelial dysfunction as their basic pathology.
Aim: To study the prevalence of microalbuminuria in patients with thyroid dysfunction.
Materials & Methods: A cross-sectional study done among 100 newly diagnosed thyroid dysfunction patients who are screened for the presence of microalbuminuria along with lipid profile, fasting and post prandial blood sugar along with clinical history. The data collected is analyzed with SPSS version 23.
Results: The prevalence of microalbuminuria in patients with thyroid dysfunction is found to be 43%. In univariate analysis, subjects with subclinical hypothyroidism had 1.08 to 5.63 times higher odds of having microalbuminuria compared to other study subjects and subjects with overt hypothyroidism had 5.03 to 40.9 times higher odds of having microalbuminuria compared to other study subjects both with a significant p value of 0.01.
Conclusion: Overt Hypothyroidism is a strong and significant predictor of microalbuminuria compared to subclinical hypothyroidism. Also an inverse relationship between the FT3 and FT4 levels with microalbuminuria is noted.
Keywords: Overt Hypothyroidism, Subclinical Hypothyroidism, endothelial dysfunction and Microalbuminuria.
References
1. Thyroid disorders in India: An epidemiological perspective. Ambika Gopalakrishnan Unnikrishnan and Usha V. Menon.Indian J Endocrinol Metab. 2011 Jul; 15(Suppl2): S78 S81.doi: 10.410-3/2230-8210.83329 PMCID: PMC3169866
2. D. H. Endemann and E. L. Schiffrin, “Endothelial dysfunction,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 1983–1992, 2004.
3. Viberti G. C., Jarrett R. J., Hill R. D., Argyropoulos A., Mahmud U., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. The Lancet. 1982;1(8287):1430–1432. doi: 10.1016/S0140-6736(82)92450-3.
4. Halimi J.-M., Hadjadj S., Aboyans V., et al. Microalbuminuria and urinary albumin excretion: French clinical practice guidelines. Diabetes & Metabolism. 2007;33(4):303–309. doi: 10.1016/-j.diabet.2007.06.001.
5. L. Palaniappan, M. Carnethon, and S. P. Fortmann, “Association between microalbuminuria and the metabolic syndrome: NHANES III,” American Journal of Hypertension, vol. 16, no. 11, pp. 952–958, 2003.
6. Clin Chim Acta. 2015 Aug 25;448:74-9. doi: 10.1016/j.cca.2015.06.010. Epub 2015 Jun 19.Central obesity is an independent risk factor for microalbuminuria in both the general Korean women and nondi-abetic nonhypertensive subpopulation: Association of microalbuminuria and metabolic syndrome from the Korea National Health and Nutrition Examination Survey 2011-2012.Rim JH1, Lee YH2, Cha BS2, Lee SG3, Kim JH4.
7. Free Triiodothyronine Concentrations Are Inversely Associated with Microalbumi-nuria.Yulin Zhou, Lei Ye, Tiange Wang, Jie Hong, Yufang Bi, Jie Zhang, Baihui Xu, Jichao Sun, Xiaolin Huang, Min Xu Int J Endocrinol. 2014; 2014: 959781. doi: 10.1155/2014/959781 PMCID: PMC4248482.
8. El-Eshmawy M. M., Abd El-Hafez H. A., El Shabrawy W. O., Abdel Aal I. A. Subclinical hypothyroidism is indepen-dently associated with microalbuminuria in a cohort of prediabetic Egyptian adults. Diabetes and Metabolism Journal. 2013; 37(6): 450–457. doi: 10.4093/dmj.2013.37.6.450.
9. S. Taddei and A. Salvetti, “Endothelial dysfunction in essential hypertension: clinical implications,” Journal of Hypertension, vol. 20, no. 9, pp. 1671–1674, 2002.
10. N. Rodondi, W. P. J. den Elzen, D. C. Bauer et al., “Subclinical hypothyroidism and the risk of coronary heart disease and mortality,” The Journal of the American Medical Association, vol. 304, no. 12, pp. 1365–1374, 2010.
11. Fukuyama K., Ichiki T., Takeda K., Tokunou T., Iino N., Masuda S., Ishibashi M., Egashira K., Shimokawa H., Hirano K., Kanaide H., Takeshita A. Downre-gulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension. 2003;41(3):598–603. doi: 10.1161/01.HYP.0000056524.35294.80.PLoS One. 2016; 11(6): e0157303. PMCID: PMC4915633.
12. Romundstad S., Holmen J., Hallan H., Kvenild K., Ellekjær H. Microalbum-inuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trøndelag Health Study (HUNT), Norway. Circulation. 2003; 108(22):2783–2789. doi: 10.1161/01.CIR.0000103667.27493.32.
13. All Components of Metabolic Syndrome Are Associated with Microa-lbuminuria in a Chinese Population. Yi-Yen Lee,1,2 Chih-Kai Yang,3 Yi-Ming Weng,3,4,6 Chung-Hsun Chuang,3,4 Wei Yu,5 Jih-Chang Chen,4,6 and Wen-Cheng Li3,4,*
14. B. Biondi and D. S. Cooper, “The clinical significance of subclinical thyroid dysfunction,” Endocrine Reviews, vol. 29, no. 1, pp. 76–131, 2008.
15. Singh and S. C. Satchell, “Microalbuminuria: causes and implications,” Pediatric Nephrology, vol. 26, no. 11, pp. 1957–1965, 2011.